Thoracic Cancer International Highlights from ESMO, ASTRO & IMiG 2025

00:00 Introductions | Dr Samantha Bowyer 01:51 Targeted Therapies | A/Prof Anthony Linton 13:51 NSCLC and SCLC | A/Prof Venessa Chin 26:02 Mesothelioma and Thymic Malignancy | A/Prof Steven Kao 40: 20 ASTRO Highlights | Prof Shalini Vinod 50:41 Discussion 59:20 Advances in Lung Cancer Therapies with CNS Activity | Sponsored by Boehringer Ingelheim 1:02:00 Advances in HER2 TKIs with High CNS Activity | A/Prof Tim Clay 1:14:00 Emerging Agents with CNS Penetration | Dr Adithya Balasubramanian 1:29:58 Immunotherapy and Brain Metastases | Prof Thomas John 1:42:24 Polling and Discussion Catch the highlights from the Thoracic Oncology Group of Australasia (TOGA) Post-ESMO, ASTRO & iMiG 2025 Symposium, where leading experts unpacked the latest breakthroughs in thoracic oncology. Includes: Prof Shalini Vinod: Updates from American Society for Radiation Oncology (ASTRO 2025) A/Prof Anthony Linton: Key insights and findings from European Society for Medical Oncology (ESMO) focusing on evolving EGFR+ disease management A/Prof Venessa Chin: Further ESMO insights focusing on bi-specific antibodies in HARMONI-6 and DeLLphi-303, but also describing MDT-Bridge- a trial that examines borderline resectable to resectable following neo-adjuvant immunotherapy A/Prof Steven Kao: Key findings from iMiG and updates in mesothelioma A/Prof Tim Clay: Advances in HER2 TKI therapies with high CNS activity (Microsatellite session) Dr Adithya Balasubramanian: Emerging CNS-penetrant therapies Prof Thomas John: CNS metastases in NSCLC treated with immunotherapy Chair: Dr Samantha Bowyer introduced and moderated the session. Whether you’re a clinician, researcher or interested in thoracic oncology innovation, this event delivers actionable updates from major 2025 international conferences for Australian thoracic cancer care.